HI
NBIX icon

Harbour Investments’s Neurocrine Biosciences NBIX Stock Holding History

Harbour Investments’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Buy
171
+49
+40% +$7.27K ﹤0.01% 2723
2026
Q1 		$16.1K Buy
122
+42
+53% +$5.57K ﹤0.01% 3004
2025
Q4 		$11.3K Sell
80
-32
-29% -$4.64K ﹤0.01% 2683
2025
Q3 		$15.7K Hold
112
– – ﹤0.01% 2469
2025
Q2 		$14.1K Buy
112
+93
+489% +$10.7K ﹤0.01% 2395
2025
Q1 		$2.1K Sell
19
-2
-10% -$253 ﹤0.01% 3076
2024
Q4 		$2.87K Sell
21
-7
-25% -$866 ﹤0.01% 2910
2024
Q3 		$3.23K Buy
28
+9
+47% +$1.23K ﹤0.01% 2778
2024
Q2 		$2.62K Sell
19
-11
-37% -$1.51K ﹤0.01% 2734
2024
Q1 		$4.14K Buy
30
+4
+15% +$546 ﹤0.01% 2566
2023
Q4 		$3.43K Hold
26
– – ﹤0.01% 2539
2023
Q3 		$2.92K Buy
26
+10
+63% +$1.05K ﹤0.01% 2447
2023
Q2 		$1.51K Buy
16
+5
+45% +$489 ﹤0.01% 2618
2023
Q1 		$1.11K Hold
11
– – ﹤0.01% 2674
2022
Q4 		$1.31K Buy
11
+9
+450% +$1.05K ﹤0.01% 2628
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2790
2022
Q2 		$0 Buy
+2
New +$185 ﹤0.01% 2790
2021
Q4 		$0 Sell
2
-110
-98% -$10.1K ﹤0.01% 3315
2021
Q3 		$11K Buy
112
+7
+7% +$661 ﹤0.01% 2617
2021
Q2 		$10K Sell
105
-46
-30% -$4.41K ﹤0.01% 2738
2021
Q1 		$15K Buy
+151
New +$15.8K ﹤0.01% 2374

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Harbour Investments's NBIX Position: Q2 2026 in Review

Harbour Investments increased its Neurocrine Biosciences (NBIX) stake by 40% in Q2 2026, buying an estimated $7.27K and bringing the position to 171 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2723.

Harbour Investments first reported a position in NBIX in Q1 2021 and has held it in 21 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Harbour Investments held 171 shares of Neurocrine Biosciences worth $28.8K as of Q2 2026.
  • Harbour Investments bought 49 Neurocrine Biosciences shares in Q2 2026, an estimated $7.27K.
  • Neurocrine Biosciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2723 holding.
  • Harbour Investments first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 21 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.